Apogee Therapeutics stock price target raised to $160 by Guggenheim on trial data

Corroborated by 1 source from 1 publisher

globalcrime2h ago

TL;DR

Apogee Therapeutics stock price target raised to $160 by Guggenheim on trial data.

Investing.com News

https://www.investing.com/news/analyst-ratings/apogee-therapeutics-stock-price-target-raised-to-160-by-guggenheim-on-trial-data-93CH-4577240